DIFFERENT TYPES OF HEPARIN IN HEMODIALYSIS - LONG-TERM EFFECTS ON POSTHEPARIN LIPASES

被引:25
作者
ARNADOTTIR, M [1 ]
KURKUS, J [1 ]
NILSSONEHLE, P [1 ]
机构
[1] UNIV LUND HOSP,DEPT CLIN CHEM,S-22185 LUND,SWEDEN
关键词
HEMODIALYSIS; HEPATIC LIPASE; LIPIDS; LIPOPROTEIN LIPASE;
D O I
10.3109/00365519409088563
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Several long-term studies of haemodialysis patients have shown improved serum lipid profile associated with treatment with low molecular weight heparin (LMWH) as compared with unfractionated heparin (UH). This has been attributed to the fact that LMWH produces a less marked acute lipolytic response than UH. However, the information on the differences in long-term effects on tissue releasable lipases is limited. Post-heparin plasma lipase activities were measured at 6, 24 and 48 h after pre-dialysis heparin injections in seven patients on chronic haemodialysis during treatment with UH; these measurements were then repeated 2 and 6 months after treatment was switched to LMWH. The curves plotted from the results can be assumed to reflect the interdialytic lipolytic potential. In the case of lipoprotein lipase this was unchanged 2 months after treatment was switched from UH to LMWH but increased by a mean of 47% after 6 months. In the case of hepatic lipase there was no change in the interdialytic lipolytic potential. Thus, there was a slow increase in tissue releasable lipoprotein lipase stores after treatment was switched from UH to LMWH, probably reflecting a smaller loss of lipoprotein lipase after each LMWH injection. Hepatic lipase, in contrast, was not affected by the type of anticoagulation.
引用
收藏
页码:515 / 521
页数:7
相关论文
共 28 条
[1]  
Akiba T, 1992, ASAIO J, V38, pM326, DOI 10.1097/00002480-199207000-00047
[2]  
APPLEBAUMBOWDEN D, 1979, METABOLISM, V28, P919
[3]   PLASMA HIGH-DENSITY LIPOPROTEIN CONCENTRATIONS IN CHRONIC-HEMODIALYSIS AND RENAL-TRANSPLANT PATIENTS [J].
BAGDADE, JD ;
ALBERS, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (25) :1436-1439
[4]   HYPERTRIGLYCERIDEMIA - A METABOLIC CONSEQUENCE OF CHRONIC RENAL FAILURE [J].
BAGDADE, JD ;
PORTE, D ;
BIERMAN, EL .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (04) :181-+
[5]   PREVALENCE OF SERUM-LIPID ABNORMALITIES IN CHRONIC-HEMODIALYSIS [J].
BRUNZELL, JD ;
ALBERS, JJ ;
HAAS, LB ;
GOLDBERG, AP ;
AGADOA, L ;
SHERRARD, DJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (08) :903-910
[6]  
CASSADER M, 1989, INT J ARTIF ORGANS, V12, P433
[7]   PATHOGENIC ROLES OF POST-HEPARIN LIPASES IN LIPID ABNORMALITIES IN HEMODIALYSIS-PATIENTS [J].
CHAN, MK ;
PERSAUD, J ;
VARGHESE, Z ;
MOORHEAD, JF .
KIDNEY INTERNATIONAL, 1984, 25 (05) :812-818
[8]   LIPID ABNORMALITIES IN UREMIA, DIALYSIS, AND TRANSPLANTATION [J].
CHAN, MK ;
VARGHESE, Z ;
MOORHEAD, JF .
KIDNEY INTERNATIONAL, 1981, 19 (05) :625-637
[9]   HEPARIN-RELEASED PLASMA LIPASES IN CHRONIC RENAL-FAILURE AND AFTER RENAL-TRANSPLANTATION [J].
CRAWFORD, GA ;
SAVDIE, E ;
STEWART, JH .
CLINICAL SCIENCE, 1979, 57 (02) :155-165
[10]   TISSUE LIPOPROTEIN-LIPASE ACTIVITY AND ITS ACTION IN LIPOPROTEIN METABOLISM [J].
CRYER, A .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1981, 13 (05) :525-541